Colorectal Cancer Trial, Recruiting (NCT07501845)

Colorectal Cancer Trial, Recruiting NCT07501845 Sponsor: Maastricht Radiation Oncology Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07501845 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older.
People who have been diagnosed with rectal cancer confirmed by a tissue sample, or where rectal cancer is strongly suspected based on medical imaging.
People whose treatment plan includes a specific radiation device called the MAASTRO HDR rectal applicator.
People who have given their consent for their health data to be collected and followed over time as part of an observational study.

Who may not be able to join:

People who do not have the mental capacity to make informed decisions about participating.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maaike Berbée, MD, PhD, Maastro

Phone: +31 88 44 55 600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07501845

Sponsor: Maastricht Radiation Oncology

Phase: Not Applicable

Status: Recruiting

Condition: Colorectal Cancer

Trial contact: +31 88 44 55 600

More information: https://clinicaltrials.gov/study/NCT07501845

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older.
People who have been diagnosed with rectal cancer confirmed by a tissue sample, or where rectal cancer is strongly suspected based on medical imaging.
People whose treatment plan includes a specific radiation device called the MAASTRO HDR rectal applicator.
People who have given their consent for their health data to be collected and followed over time as part of an observational study.

Who may not be able to join:

People who do not have the mental capacity to make informed decisions about participating.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Maastricht Radiation Oncology

Registry

ClinicalTrials.gov

Start date

23 March 2026

Est. completion

1 April 2034

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Efficacy of Maastro applicator endoluminal HDR contact brachytherapy boosting in functional organ sparing of the rectum.; Percentage of planned interventional Maastro procedures that could be conducted successfully from a procedural point of view.; Duration of the application procedure.; Clinical complete response rate up to 5 years after treatment.; Toxcity up to 3 year after treatment; Disease status up to 10 years after treatment; Salvage surgery; Overall and disease specific survival rate; Discomfort/pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov